Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online

Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial

Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China

Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online

PDF) Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis?

Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C - William Kemp, Stuart Roberts, 2011

Full article: Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada

The way forward in HCV treatment — finding the right path

A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C - Chen - 2022 - JGH Open - Wiley Online Library

Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease - Clinical Gastroenterology and Hepatology

Pegylated interferon alfa-2a - wikidoc

Treatment - Hepatitis C Online

120mcg Pegintron Peginterferon Alfa-2b Injection, Treatment: Chronic Hepatitis C

Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial - The Lancet Gastroenterology & Hepatology